Profile of:

Alexandre Sepriano


Full name: Alexandre Sepriano

Current country: Portugal

Membership level: Full

Type of membership: Member

Number of publications: 17

Axial spondyloarthritis (2025)
https://pubmed.ncbi.nlm.nih.gov/39798984/

Exploring the unifying concept of spondyloarthritis: a latent class analysis of the REGISPONSER registry (2024)
https://pubmed.ncbi.nlm.nih.gov/38237920/

Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis (2024)
https://pubmed.ncbi.nlm.nih.gov/38305346/

Clinical and imaging outcomes of different phenotypes of axial spondyloarthritis: 5-year analysis of the DESIR cohort (2024)
https://pubmed.ncbi.nlm.nih.gov/38479110/

Change in different classes of chronic back pain suspicious of axial spondyloarthritis: a latent transition analysis of the SPACE cohort (2024)
https://pubmed.ncbi.nlm.nih.gov/39349053/

Late-onset axial spondyloarthritis: A multicentre nationwide study (2024)
https://pubmed.ncbi.nlm.nih.gov/39481638/

Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial (2023)
https://pubmed.ncbi.nlm.nih.gov/37407237/

Bone marrow edema in the sacroiliac joints is associated with the development of structural lesions at the same anatomical location over time in patients with axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37263068/

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update (2023)
https://pubmed.ncbi.nlm.nih.gov/36270658/

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/36270657/

Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/36261247/

Role of vertebral corner inflammation and fat deposition on MRI on syndesmophyte development detected on whole spine low-dose CT scan in radiographic axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35803614/

Axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34615639/

Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference (2021)
https://pubmed.ncbi.nlm.nih.gov/34253683/

Which imaging outcomes for axSpA are most sensitive to change? A 5-Year analysis of The DESIR Cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/32976683/

Integrated longitudinal analysis does not compromise precision and reduces bias in the study of imaging outcomes: A comparative 5-year analysis in the DESIR cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/32209237/

What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts (2020)
https://pubmed.ncbi.nlm.nih.gov/31980546/